Conference Programme 2025

Subpage Hero

     

Loading

From diagnosis to regeneration: non-invasive, safe and innovative partners in bone health strategies – meet Echolight REMS and MBST

27 Nov 2025
Theatre B
Modalities & Techniques

Echolight REMS (Radiofrequency Echographic Multi Spectrometry) is a non-invasive, radiation-free diagnostic tool that uses ultrasound technology to assess bone density and quality. Unlike traditional DEXA scans, Echolight REMS provides immediate and detailed results, including T-scores, Z-scores, and a Fragility Score, which offers a clearer picture of fracture risk by evaluating bone microarchitecture. Its safety and portability make it suitable for a wide range of patients, including pregnant women, children, and those with conditions precluding conventional X-ray exposure.
MBST (Magnetic Resonance Therapy) is a non-invasive treatment that focuses on stimulating bone cell regeneration at the cellular level. It aims to rebuild bone density and address the root cause of conditions like osteopenia and osteoporosis, rather than just managing symptoms. The therapy uses magnetic resonance conditions to promote natural regeneration, improving bone mass and supporting long-term bone health with no known side effects.
Together, Echolight REMS and MBST offer a holistic approach to bone health: Echolight REMS provides accurate, early diagnosis and risk assessment, which then guides personalized MBST therapy to stimulate bone regeneration and reduce fracture risk, moving from initial diagnosis to active regeneration of bone tissue.

Learning outcomes
# Bone health matters
# Health starts in the cell
# Prevention & exercise are key 
# Echolight REMS is a non-invasive, radiation-free diagnostic technology used for assessing bone density, quality, and fracture risk, providing a unique Fragility Score
# tNRM / MBST® (Magnetic Resonance Therapy) is a non-invasive treatment that stimulates bone cell regeneration, aiming to improve bone density and support long-term bone health.
# tNMR can help regulating the cellular clock, hypoxic signalling as well as anabolic/catabolic and anti-inflammatory processes
# The combined application of Echolight REMS and MBST® can offer a comprehensive strategy for bone health, spanning from early diagnosis to active tissue regeneration.
# Screen my bones – a campaign that can help detecting osteoporosis, reframes how we think about bone health and to make assessment more accessible.

Speakers
Gary Rhodes, Founder - Screen My Bones
Anna Scheiner, Chief Medical Officer - MBST Global, MedTec Medizintechnik GmbH

Partners

MSK HQ Official Sponsor

  

MSK HQ Education Partner

  

MSK HQ Education Partner

   

MSK HQ Education Partner

    

Education Partner

  

Education Partner

  

Education Partner

Venn

Event sponsor

   

Event Partner

  

Event Partner

  

Event Partner

    

Event Partner

    

Event Partner

    

Event Partner

  

Event Partner

   

Event Partner

   

Show Guide Sponsor

   

Media Partner